DK292590D0 - Rifapentin-hydrohalogenider - Google Patents

Rifapentin-hydrohalogenider

Info

Publication number
DK292590D0
DK292590D0 DK292590A DK292590A DK292590D0 DK 292590 D0 DK292590 D0 DK 292590D0 DK 292590 A DK292590 A DK 292590A DK 292590 A DK292590 A DK 292590A DK 292590 D0 DK292590 D0 DK 292590D0
Authority
DK
Denmark
Prior art keywords
pct
rifapentine
sec
date
hydrohalides
Prior art date
Application number
DK292590A
Other languages
English (en)
Other versions
DK292590A (da
DK173423B1 (da
Inventor
Emilio Occelli
Marino Nebuloni
Bruno Cavalleri
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of DK292590D0 publication Critical patent/DK292590D0/da
Publication of DK292590A publication Critical patent/DK292590A/da
Application granted granted Critical
Publication of DK173423B1 publication Critical patent/DK173423B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Dental Preparations (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK199002925A 1988-07-13 1990-12-10 Rifapentin-hydrohalogenider, fremgangsmåde til fremstilling deraf, farmaceutisk dosisform indeholdende dem samt deres anven DK173423B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8816620 1988-07-13
GB888816620A GB8816620D0 (en) 1988-07-13 1988-07-13 Rifapentine hydrohalides
EP8900694 1989-06-21
PCT/EP1989/000694 WO1990000553A1 (en) 1988-07-13 1989-06-21 Rifapentine hydrohalides

Publications (3)

Publication Number Publication Date
DK292590D0 true DK292590D0 (da) 1990-12-10
DK292590A DK292590A (da) 1990-12-10
DK173423B1 DK173423B1 (da) 2000-10-09

Family

ID=10640347

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199002925A DK173423B1 (da) 1988-07-13 1990-12-10 Rifapentin-hydrohalogenider, fremgangsmåde til fremstilling deraf, farmaceutisk dosisform indeholdende dem samt deres anven

Country Status (20)

Country Link
US (1) US5306715A (da)
EP (1) EP0440642B1 (da)
JP (1) JP2716553B2 (da)
KR (1) KR0135312B1 (da)
CN (1) CN1039421A (da)
AT (1) ATE111101T1 (da)
AU (1) AU632754B2 (da)
CA (1) CA1339215C (da)
DE (1) DE68918107T2 (da)
DK (1) DK173423B1 (da)
ES (1) ES2018374A6 (da)
GB (1) GB8816620D0 (da)
GR (1) GR1002222B (da)
HK (1) HK1005455A1 (da)
HU (1) HU210716A9 (da)
IE (1) IE65812B1 (da)
IL (1) IL90892A0 (da)
PT (1) PT91132B (da)
WO (1) WO1990000553A1 (da)
ZA (1) ZA894991B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0536197B1 (en) * 1990-06-29 1995-07-26 GRUPPO LEPETIT S.p.A. Pure crystalline form of rifapentine
HRP20000162B1 (en) 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
JP4393098B2 (ja) * 2002-06-21 2010-01-06 独立行政法人科学技術振興機構 アンサマイシン系抗生物質の新規用途及び新規血管新生抑制物質のスクリーニング方法
WO2004072040A1 (en) * 2003-02-12 2004-08-26 Ciba Specialty Chemicals Holding Inc. Crystalline forms of pitavastatin calcium
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
SI1698630T1 (sl) * 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
JP2007246514A (ja) * 2006-02-14 2007-09-27 Toyama Chem Co Ltd ピペラシリンナトリウムの新規な結晶
EP2128162A4 (en) * 2007-01-31 2011-05-25 Toyama Chemical Co Ltd NEW CRYSTAL OF PIPERACILIN SODIUM
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
WO2013112809A2 (en) * 2012-01-25 2013-08-01 Salix Pharmaceuticals, Ltd Rifaximin derivative and uses thereof
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2022225384A1 (es) * 2021-04-21 2022-10-27 Interquim, S.A. De C.V. Proceso de obtención de rifapentina. con una nueva forma cristalina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (da) * 1964-07-31
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
FR2309556A1 (fr) * 1975-04-29 1976-11-26 Aries Robert Aminoguanidines derivees de la rifamycine
US4876258A (en) * 1987-08-13 1989-10-24 Ciba-Geigy Corporation Biphenylyl compounds
JPH02501301A (ja) * 1987-09-25 1990-05-10 チバ‐ガイギー　アクチェンゲゼルシャフト ４‐（トリアルキルベンジル）‐ピペラジニル化合物のジアシル誘導体

Also Published As

Publication number Publication date
KR0135312B1 (ko) 1998-04-23
AU632754B2 (en) 1993-01-14
IL90892A0 (en) 1990-02-09
EP0440642A1 (en) 1991-08-14
GR890100448A (el) 1990-06-27
JPH03506025A (ja) 1991-12-26
PT91132B (pt) 1994-12-30
IE65812B1 (en) 1995-11-15
ATE111101T1 (de) 1994-09-15
AU3770289A (en) 1990-02-05
JP2716553B2 (ja) 1998-02-18
CN1039421A (zh) 1990-02-07
HK1005455A1 (en) 1999-01-08
PT91132A (pt) 1990-02-08
DE68918107T2 (de) 1995-01-26
DK292590A (da) 1990-12-10
DE68918107D1 (de) 1994-10-13
WO1990000553A1 (en) 1990-01-25
CA1339215C (en) 1997-08-05
ES2018374A6 (es) 1991-04-01
EP0440642B1 (en) 1994-09-07
DK173423B1 (da) 2000-10-09
IE892247L (en) 1990-01-13
GB8816620D0 (en) 1988-08-17
HU210716A9 (en) 1995-06-28
US5306715A (en) 1994-04-26
KR900701798A (ko) 1990-12-04
ZA894991B (en) 1990-08-29
GR1002222B (en) 1996-04-17

Similar Documents

Publication Publication Date Title
IT1230779B (it) Procedimento per preparare 1,1,1,2 tetrafluoroetano.
ATE111101T1 (de) Rifapentin-hydrohalide.
FI890403A0 (fi) Kalander, saerskilt en superkalander.
IT1215759B (it) Unita' di scorrimento ad ampia registrabilita' per macchine operatrici.
DK455088D0 (da) Syntetiske receptoranaloger
DE69021324D1 (de) Tisch zum positionieren.
IT1230795B (it) Procedimento per preparare 1,1,1,2 tetrafluoroetano da 1,1 dicloro 1,2,2,2 tetrafluoroetano.
ES543517A0 (es) Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona.
ATE161713T1 (de) Feuchtigkeitsspender
FI901213A0 (fi) Substituerade (kinolin-2-ylmetoxi) fenyl-n,n'-sulfonylurinaemnen, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES2019098B3 (es) Procedimiento para preparar halogenuros de 1-metil-3,5,7-triaza-1-azoniatriciclodecano.
TR27699A (tr) 2,3,5,6-tetrakloropiridin hazirlamaya mahsus bir yöntem.
EP0566666A4 (en) Novel glucohydrolase inhibitors useful as antidiabetic agents
ES545622A0 (es) Un procedimiento para preparar bisarilamidas de n,n'-di(1 aminoalquil-2) alquilendiaminas.
ES540589A0 (es) Un procedimiento para preparar 2-arilimidazo (4,5-c) piridi-nas.
NO905244L (no) Fremgangsmaate for fremstilling av des(64,65)-proinsulin.
FR2654968B1 (fr) Machine de rodage par expansion d'alesages.
DE68900131D1 (de) Biozide 4,5-dichlor-1,2-dithiol-3-on-zusammensetzung.
DE3577559D1 (de) 4h-pyrimido(2,1-a)isochinolin-4-onderivate.
IT1227852B (it) Procedimento per preparare derivati della 1,5 benzotiazepina.
NO159842C (no) Dempeventil for ko en tr aktor.
EP0630904A4 (en) Novel nicotine derivative.
ES554039A0 (es) Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-tetrahidro-1,5-benzoxazepina.
ATE35507T1 (de) Neue 4,5-g(a)epoxymorphinan-6-spiro-2'-(4'karboxy-1',3'-thiazolidin)-abkoemmlinge.
ATE63546T1 (de) 3,6 bis(substituierte) acridinderivate.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired